FEATURED June 25, 2026What the Immune System Does When You’re Not Sick—and Why It Matters for Aging
- July 20, 2026
MHS Degree Program Welcomes Class of 2028
- July 17, 2026
Women’s Health Research at Yale Funds Projects on Obesity and Ovarian Aging, Diabetes, Cancers, and Autoimmunity
- July 08, 2026
National Cancer Institute Grant Will Support Espinosa’s Leukemia Research
- July 06, 2026
Dr. Mohammed Ali Receives 2026 JH Milstone Award in Hematology
Vascular Biology and Therapeutics Program
An interdisciplinary program combining the strengths of Yale’s basic science and clinician faculty
The Vascular Biology and Therapeutics (VBT) Program is the first and largest interdepartmental program at Yale School of Medicine (YSM). VBT faculty are recognized as some of the best in the world, consistently making national and international scientific contributions in the field of vascular biology.
The program integrates groundbreaking discoveries in vascular biology with closely allied clinical programs in Medicine and Surgery to enhance the diagnosis and treatment of cardiovascular disorders. The VBT program integrates 56 research laboratories, 17 primary labs housed at the Amistad Research Building, and 39 affiliated laboratories. These faculty labs are from 18 departments/divisions/sections in two schools (Medical School and Faculty Arts and Sciences).
Areas of Focus
The VBT program focuses on five broad areas of investigation:
- Immunobiology and Metabolism in Cardiovascular Disease
- Novel Mechanism of Cardiovascular Disease
- Human Genetics, Novel Technologies and Cardiovascular Imaging
- Vascular Aging and Regeneration
- Neurovascular Disease